Intratympanic dexamethasone up-regulates Fkbp5 in the cochleae of mice in vivo

Yukihide Maeda, Kunihiro Fukushima, Shin Kariya, Yorihisa Orita, Kazunori Nishizaki

Research output: Contribution to journalArticle

7 Citations (Scopus)

Abstract

Conclusions: Quantitative, real-time RT-PCR demonstrated that intratympanic dexamethasone significantly up-regulates the expression of Fkbp5 in cochleae of mice in vivo. The immunohistochemistry results showed fundamentally ubiquitous expression of Fkbp5 in cochlear structures, with relatively strong expression in type 4 fibrocytes and weak signal in the inner hair cells. These data indicate that dexamethasone regulates gene expression at the level of transcription in vivo and that this process is basically ubiquitous in the cochlea. Objectives: To demonstrate that intratympanically applied dexamethasone up-regulates Fkbp5 in the cochlea in vivo. Methods: Dexamethasone or control saline were intratympanically applied to adult C57/BL6 mice and dexamethasone-dependent changes in the levels of Fkbp5 expression in the cochlea were analyzed using quantitative real-time RT-PCR. The expression pattern of Fkbp5 in cochlea was investigated by immunohistochemistry in mice that were administered dexamethasone and in controls. Results: Quantitative real-time RT-PCR demonstrated significant increases of Fkbp5 expression levels in cochleae of dexamethasone-treated mice as compared with controls at 12 h after application (244.8 ± 155.5, n = 5 vs 100.0 ± 3.0, n = 6, p <0.01). Immunohistochemistry showed fundamentally ubiquitous expression of Fkbp5 in cochlear structures, with some strongly positive fibrocytes in the spiral ligaments and weak immunoreactivity in the inner hair cells. Distribution of Fkbp5 signaling was not different between the dexamethasone-treated group and controls.

Original languageEnglish
Pages (from-to)4-9
Number of pages6
JournalActa Oto-Laryngologica
Volume132
Issue number1
DOIs
Publication statusPublished - Jan 2012

Fingerprint

Cochlea
Dexamethasone
Up-Regulation
Inner Auditory Hair Cells
Real-Time Polymerase Chain Reaction
Immunohistochemistry
Spiral Ligament of Cochlea
Gene Expression
Control Groups

Keywords

  • Gene expression
  • Glucocorticoid
  • Immunohistochemistry
  • Quantitative real-time RT-PCR
  • Sensorineural hearing loss

ASJC Scopus subject areas

  • Otorhinolaryngology

Cite this

Intratympanic dexamethasone up-regulates Fkbp5 in the cochleae of mice in vivo. / Maeda, Yukihide; Fukushima, Kunihiro; Kariya, Shin; Orita, Yorihisa; Nishizaki, Kazunori.

In: Acta Oto-Laryngologica, Vol. 132, No. 1, 01.2012, p. 4-9.

Research output: Contribution to journalArticle

@article{41f45385265a462fa5426a035b0b9367,
title = "Intratympanic dexamethasone up-regulates Fkbp5 in the cochleae of mice in vivo",
abstract = "Conclusions: Quantitative, real-time RT-PCR demonstrated that intratympanic dexamethasone significantly up-regulates the expression of Fkbp5 in cochleae of mice in vivo. The immunohistochemistry results showed fundamentally ubiquitous expression of Fkbp5 in cochlear structures, with relatively strong expression in type 4 fibrocytes and weak signal in the inner hair cells. These data indicate that dexamethasone regulates gene expression at the level of transcription in vivo and that this process is basically ubiquitous in the cochlea. Objectives: To demonstrate that intratympanically applied dexamethasone up-regulates Fkbp5 in the cochlea in vivo. Methods: Dexamethasone or control saline were intratympanically applied to adult C57/BL6 mice and dexamethasone-dependent changes in the levels of Fkbp5 expression in the cochlea were analyzed using quantitative real-time RT-PCR. The expression pattern of Fkbp5 in cochlea was investigated by immunohistochemistry in mice that were administered dexamethasone and in controls. Results: Quantitative real-time RT-PCR demonstrated significant increases of Fkbp5 expression levels in cochleae of dexamethasone-treated mice as compared with controls at 12 h after application (244.8 ± 155.5, n = 5 vs 100.0 ± 3.0, n = 6, p <0.01). Immunohistochemistry showed fundamentally ubiquitous expression of Fkbp5 in cochlear structures, with some strongly positive fibrocytes in the spiral ligaments and weak immunoreactivity in the inner hair cells. Distribution of Fkbp5 signaling was not different between the dexamethasone-treated group and controls.",
keywords = "Gene expression, Glucocorticoid, Immunohistochemistry, Quantitative real-time RT-PCR, Sensorineural hearing loss",
author = "Yukihide Maeda and Kunihiro Fukushima and Shin Kariya and Yorihisa Orita and Kazunori Nishizaki",
year = "2012",
month = "1",
doi = "10.3109/00016489.2011.619571",
language = "English",
volume = "132",
pages = "4--9",
journal = "Acta Oto-Laryngologica",
issn = "0001-6489",
publisher = "Informa Healthcare",
number = "1",

}

TY - JOUR

T1 - Intratympanic dexamethasone up-regulates Fkbp5 in the cochleae of mice in vivo

AU - Maeda, Yukihide

AU - Fukushima, Kunihiro

AU - Kariya, Shin

AU - Orita, Yorihisa

AU - Nishizaki, Kazunori

PY - 2012/1

Y1 - 2012/1

N2 - Conclusions: Quantitative, real-time RT-PCR demonstrated that intratympanic dexamethasone significantly up-regulates the expression of Fkbp5 in cochleae of mice in vivo. The immunohistochemistry results showed fundamentally ubiquitous expression of Fkbp5 in cochlear structures, with relatively strong expression in type 4 fibrocytes and weak signal in the inner hair cells. These data indicate that dexamethasone regulates gene expression at the level of transcription in vivo and that this process is basically ubiquitous in the cochlea. Objectives: To demonstrate that intratympanically applied dexamethasone up-regulates Fkbp5 in the cochlea in vivo. Methods: Dexamethasone or control saline were intratympanically applied to adult C57/BL6 mice and dexamethasone-dependent changes in the levels of Fkbp5 expression in the cochlea were analyzed using quantitative real-time RT-PCR. The expression pattern of Fkbp5 in cochlea was investigated by immunohistochemistry in mice that were administered dexamethasone and in controls. Results: Quantitative real-time RT-PCR demonstrated significant increases of Fkbp5 expression levels in cochleae of dexamethasone-treated mice as compared with controls at 12 h after application (244.8 ± 155.5, n = 5 vs 100.0 ± 3.0, n = 6, p <0.01). Immunohistochemistry showed fundamentally ubiquitous expression of Fkbp5 in cochlear structures, with some strongly positive fibrocytes in the spiral ligaments and weak immunoreactivity in the inner hair cells. Distribution of Fkbp5 signaling was not different between the dexamethasone-treated group and controls.

AB - Conclusions: Quantitative, real-time RT-PCR demonstrated that intratympanic dexamethasone significantly up-regulates the expression of Fkbp5 in cochleae of mice in vivo. The immunohistochemistry results showed fundamentally ubiquitous expression of Fkbp5 in cochlear structures, with relatively strong expression in type 4 fibrocytes and weak signal in the inner hair cells. These data indicate that dexamethasone regulates gene expression at the level of transcription in vivo and that this process is basically ubiquitous in the cochlea. Objectives: To demonstrate that intratympanically applied dexamethasone up-regulates Fkbp5 in the cochlea in vivo. Methods: Dexamethasone or control saline were intratympanically applied to adult C57/BL6 mice and dexamethasone-dependent changes in the levels of Fkbp5 expression in the cochlea were analyzed using quantitative real-time RT-PCR. The expression pattern of Fkbp5 in cochlea was investigated by immunohistochemistry in mice that were administered dexamethasone and in controls. Results: Quantitative real-time RT-PCR demonstrated significant increases of Fkbp5 expression levels in cochleae of dexamethasone-treated mice as compared with controls at 12 h after application (244.8 ± 155.5, n = 5 vs 100.0 ± 3.0, n = 6, p <0.01). Immunohistochemistry showed fundamentally ubiquitous expression of Fkbp5 in cochlear structures, with some strongly positive fibrocytes in the spiral ligaments and weak immunoreactivity in the inner hair cells. Distribution of Fkbp5 signaling was not different between the dexamethasone-treated group and controls.

KW - Gene expression

KW - Glucocorticoid

KW - Immunohistochemistry

KW - Quantitative real-time RT-PCR

KW - Sensorineural hearing loss

UR - http://www.scopus.com/inward/record.url?scp=84455191994&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84455191994&partnerID=8YFLogxK

U2 - 10.3109/00016489.2011.619571

DO - 10.3109/00016489.2011.619571

M3 - Article

VL - 132

SP - 4

EP - 9

JO - Acta Oto-Laryngologica

JF - Acta Oto-Laryngologica

SN - 0001-6489

IS - 1

ER -